Grail is a leader in the potentially enormous multi-cancer early detection (MCED) test market. The company could have a major catalyst on the way with the potential FDA approval of its Galleri test.

One problem for Grail is that some lump it into the same category as other genomics stocks that focus on prenatal screening. This group has become increasingly crowded. However, Grail is different -- ...

Ask some people about Grail (NASDAQ: GRAL), and a Monty Python movie will probably come to mind. The innovative pioneer of liquid biopsies (blood tests that can detect cancer) continues to fly under ...

Ademola Balogun specializes in building practical AI solutions for real-world problems. Retrieval-Augmented Generation solved the hallucination problem. Then everyone discovered it can't actually ...

When I write on Note every day, sometimes I find that I have nothing I want to write about. So, I decided to stop forcing myself to write. Instead, I decided to have my AI partner choose the perfect ...

Callum is a seasoned gaming managing editor for a number of publications and a gamer who will always try to shine a spotlight on indie games before giving AAA titles the time of day. He loves nothing ...

The 2025 Palm Beach Post Pathfinder Award winners were announced via video May 9, honoring a collection of 18 extraordinary high school seniors from Palm Beach and Martin counties. Each first-place ...

One of the most effective ways to introduce kids to programming is through games. Coding games blend learning with play thus creating a space where kids can build real skills without feeling like they ...